Arterial Function Should Be Focused in the Follow-Up Treatment of Covid-19 Mild Patients

Jinbo Liu, Jie Chen and Hongyu Wang^*

Department of Vascular Medicine, Vascular Health Research Center of Peking University Health Science Center, Peking University Shougang Hospital, Beijing, P.R. of China

*Corresponding Author: Dr. Hongyu WangDepartment of Vascular Medicine, Vascular Health Research Center of Peking University Health Science Center, Peking University Shougang Hospital, Beijing 100144, P.R. of China. E-mail: dr.hongyuwang@foxmail.com

Received: March 02, 2021; Accepted: March 18, 2021; Published: March 26, 2021

The novel Coronavirus Disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the greatest medical challenge in decades. We provide a comprehensive review of the clinical course of COVID-19, its comorbidities, and mechanistic considerations for future therapies. While COVID-19 primarily affects the lungs, causing interstitial pneumonitis and severe Acute Respiratory Distress Syndrome (ARDS), it also affects multiple organs, particularly the cardiovascular system.